Literature DB >> 4749274

Inhibition of the biosynthesis of sterols by phenyl and phenolic compounds in rat liver.

S Ranganathan, T Ramasarma.   

Abstract

The presence of mitochondria increased the incorporation of [2-(14)C]mevalonate into sterols in a cell-free system from rat liver. Various phenyl and phenolic compounds inhibited the incorporation of mevalonate when added in vitro. p-Hydroxycinnamate, a metabolite of tyrosine, was the most powerful inhibitor among the compounds tested. Catechol, resorcinol and quinol were inhibitory at high concentrations. Organic acids lacking an aromatic ring were not inhibitory. Two hypocholesterolaemic drugs, Clofibrate (alpha-p-chlorophenoxyisobutyrate) and Clofenapate [alpha,4-(p-chlorophenyl)phenoxyisobutyrate], which are known to affect some step before the formation of mevalonate in the biosynthesis of cholesterol in vivo, showed inhibition at a step beyond the formation of mevalonate in vitro. The presence of the aromatic ring and the carboxyl group in a molecule appears to be necessary for the inhibition.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4749274      PMCID: PMC1177870          DOI: 10.1042/bj1340737

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

1.  Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate.

Authors:  J M THORP; W S WARING
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Phenylalanine inhibition of tyrosine metabolism in the liver.

Authors:  I J BICKIS; J P KENNEDY; J H QUASTEL
Journal:  Nature       Date:  1957-06-01       Impact factor: 49.962

3.  Proceedings of the Biochemical Society.

Authors: 
Journal:  Biochem J       Date:  1954-01       Impact factor: 3.857

4.  Inhibition of sterol synthesis in vitro by metabolites of phenylalanine.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  Biochim Biophys Acta       Date:  1969

5.  Inhibition of in vitro sterol biosynthesis by phenylalanine.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  Biochim Biophys Acta       Date:  1968-12-18

6.  Biosynthesis of cholesterol by the bovine aorta and the mechanism of action of alpha-para-chlorophenoxyisobutyric acid.

Authors:  M R Walsh; S W Teal; W Gamble
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

7.  Effect of alpha-p-chlorophenoxyisobutyrate on the metabolism of isoprenoid compounds in the rat.

Authors:  K V Krishnaiah; T Ramasarma
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

  7 in total
  7 in total

1.  Effect of clofibrate on brain mevalonate-5-pyrophosphate decarboxylase.

Authors:  M F Zafra; S Riquelme; M Castillo; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

2.  The regulation of the biosynthesis of ubiquinone in the rat.

Authors:  S Ranganathan; T Ramasarma
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

3.  Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.

Authors:  C Shama Bhat; T Ramasarma
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

4.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

Review 5.  Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes.

Authors:  Roseanne O Yeung; Fady Hannah-Shmouni; Karen Niederhoffer; Mark A Walker
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

6.  Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis.

Authors:  M Castillo; M Martinez-Cayuela; M F Zafra; E Garcia-Peregrin
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

7.  Further studies on mevalonate phosphorylation in neonatal chick brain.

Authors:  A Linares; J A Aguilera; E García-Peregrín
Journal:  Neurochem Res       Date:  1981-08       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.